Geographically, North America dominates the testosterone replacement therapy market driven by best in class infrastructure, easy access to healthcare, higher awareness about the disease amongst citizens as well as practitioners, and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest markets for testosterone replacement therapy market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China and India in this region.
This report identifies the global testosterone replacement therapy market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the testosterone replacement therapy market.
This report segments the testosterone replacement therapy market on the basis of therapies and regional market as follows:
Testosterone Replacement Therapy Market research report is classified on the basis of therapies. Some of the major therapies covered in this report are as follows: Injections, Pallets, Gels, Patches
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the testosterone replacement therapy market. Some of the major companies’ profiles in detail are as follows:
Antares Pharma Inc.
Bayer HealthCare Pharmaceuticals
Columbia Laboratories Inc.
Eli Lilly and Company
Endo Pharmaceuticals Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Testosterone Replacement Therapy Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Testosterone Replacement Therapy Market– Forces
4.2. Increasing global population with testosterone problems due to life style changes
4.3.1. Side effect and increased risk of heart strokes
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Degree of Competition
5. Testosterone Replacement Therapy Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Testosterone Replacement Therapy Market, By Therapies
7. Testosterone Replacement Therapy Market, By Geography
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.4. Rest of the World (RoW)
7.4.2. Rest of RoW
8. Testosterone Replacement Therapy Market – Entropy
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Acrux Limited
9.2. Actavis Inc.
9.3. Antares Pharma Inc.
9.4. Bayer HealthCare Pharmaceuticals
9.5. Columbia Laboratories Inc.
9.6. Eli Lilly and Company
9.7. Endo Pharmaceuticals Inc.
9.8. ProStrakan Group Plc.
9.9. Juniper Pharmaceuticals
9.10. Pfizer Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10.3. Research Methodology
10.5. Compilation of Expert Insights